CD43 regulates T-cell function and survival in a context-dependent manner 2299796
Abstract
Abstract Introduction CD43 (sialophorin) is a sialomucin widely expressed on hematopoietic cells that governs T-cell adhesion, trafficking, and activation. We tested whether CD43 sets proliferation and survival thresholds in T-cell subsets. Methods Lymph-node T cells from WT and CD43KO C57BL/6 mice were stimulated with anti-CD3/CD28 or PMA/ionomycin; proliferation (CFSE), viability, Bax/Bcl-xL, and GLUT1, CD25, and CD69 were quantified by flow cytometry. For antigen-specific responses, CFSE-labeled OT-I/OT-II WT or CD43KO T cells were adoptively transferred into OVA-immunized recipients. Results Under anti-CD3/CD28, CD43KO CD4 and CD8 proliferated less than WT, indicating that CD43 supports TCR/CD28-driven activation. With PMA/ionomycin, CD43KO CD4 proliferated less, whereas CD43KO CD8 proliferated more. Loss of CD43 pushed CD4 toward a pro-apoptotic, hypoproliferative state characterized by an increased Bax/Bcl-xL ratio, while CD43KO CD8 retained a balanced Bax/Bcl-xL and showed more GLUT1+ and CD69+ cells, consistent with elevated metabolic/activation thresholds. CD25 was unchanged. In vivo, OT-I CD43KO cells expanded 5-fold over WT, whereas OT-II CD43KO cells expanded 4-fold less than WT. Conclusion CD43 has a context-dependent, subset-specific role in T-cell responses differentially tuning CD4+ and CD8+ activation and expansion. CD4+ cells are more prone to activation-induced death and require CD43 for proper expansion, whereas CD8+ cells are restrained by CD43, limiting excessive activation. Thus, CD43 shapes the magnitude and quality of T-cell immunity across contexts. Funding Source Funded by DGAPA/UNAM IN222523, Postdoctoral fellow by SECIHTI, 6002103. Topic Categories Immune Response Regulation: Molecular Mechanisms (IRM)
Article Details
Journal Info
The Journal of Immunology
American Association of Immunologists
Authors (4)
Veronica Rojo Leon
Instituto de Biotecnología
Luis Eduardo Chipres Naranjo
Instituto de Biotecnología
Erika Melchy-Perez
Instituto de Biotecnología
Yvonne Jane Rosenstein Azoulay
Instituto de Biotecnología